Antidepressant could slow Parkinson’s disease
Nortriptyline, which has been used to treat depression has been found to stop the growth of abnormal proteins on the brain...
List view / Grid view
Nortriptyline, which has been used to treat depression has been found to stop the growth of abnormal proteins on the brain...
INTEGRA is making multichannel pipetting quicker and easier than ever before...
The FDA has granted orphan drug designation for ApoGraft for the prevention of acute and chronic graft versus host disease...
A long-term study has found that low cumulative exposure to benzodiazepine does not affect cognition in schizophrenia...
The Advance Value Framework has addressed the pitfalls of current approaches assessing the value of new medicines...
This month, 800+ life science leaders will gather in Boston for the tenth annual BioPharm America™ life science partnering event, September 26–27 at the Sheraton Boston Hotel...
Researchers have found that asthma medicine can halve a patient's risk of developing Parkinson's disease...
The FDA has approved Mylotarg for the treatment of adults with newly diagnosed acute myeloid leukaemia whose tumours express the CD33 antigen...
Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
A team of researchers have found that a common heart disease medication may help treat lung disease...
The real extent of the pharma sector’s problem with data breaches has been revealed...
The FDA has approved CAR T cell therapy for treatment of children with acute lymphoblastic leukemia...
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer...
Researchers have made what are believed to be two world first discoveries: an MRI that can measure kidney damage and predict future kidney function...
Researchers have found that a diabetes drug may help in certain types of Parkinson’s disease...